Bringing the Oncology Community Together

Breast Cancer

OncLive TV - A Network of Your Peers

Dr. Perez Discusses Optimizing Adjuvant Therapy

Dr. Schnabel on Predicting Breast Cancer by Atypia Type

Dr. Harvey on Aromatase Inhibitor Treatment Duration

Dr. Bloom Explains Situations Requiring HER2 Retesting

Dr. Burris Discusses the Stratification of Clinical Trials

>>> More Breast Cancer Videos

2 Landmark Trials Suggest Changes in Practice; Brachytherapy Controversy Attracts Attention

This commentary will highlight 2 phase III randomized trials and a retrospective review of a large national database that has been strongly criticized based on its overall conclusions.

Oncology Live > Conference Highlights

Premature Tamoxifen Withdrawal Is Common in Male Patients With Breast Cancer

New data show that roughly one-fifth of tamoxifen-treated male patients with breast cancer stop treatment early because of side effects.

Oncology & Biotech News > Clinical Trial Reports

Navigation Program Shows Limited Benefit in Underserved, Urban Women With Breast Cancer

The use of a navigation program for an urban safety net breast cancer population has only a moderate effect on the time from symptom presentation to treatment.

Oncology & Biotech News > Clinical Trial Reports

Breast Cancer is Diagnosed Later in Men but Is Less Often Fatal

New data show that while men are diagnosed with breast cancer at a mere fraction of the rate of women, they tend to have more advanced disease at the time of diagnosis.

Oncology & Biotech News > Clinical Trial Reports

Anastrozole Plus Fulvestrant Improved Survival in Metastatic Hormone Receptor-Positive Breast Cancer

The combination of anastrozole and fulvestrant improved survival when used as first-line therapy in postmenopausal women with metastatic HR-positive breast cancer compared with anastrozole alone.

Oncology & Biotech News > Conference Highlights